Retrospective Analysis of Real-World Use of Cefiderocol in the Management of Gram-Negative Infections as part of the Early Access Program (PERSEUS Study).
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
SHINOGI SLU
Cita
Retrospective Analysis of Real-World Use of Cefiderocol in the Management of Gram-Negative Infections as part of the Early Access Program (PERSEUS Study). (2020-266-4). SHINOGI SLU. 2023-2024. IP:PAULA RAMÍREZ GALLEYMORE.
Portal de investigación